ストックスクリーナーアプリを入手
0.431
4.92%
0.0202
前日終値:
$0.4108
開ける：
$0.41
24時間の取引高:
31,869
Relative Volume:
0.05
時価総額：
$2.06M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+8.45%
1か月 パフォーマンス:
+13.96%
6か月 パフォーマンス:
+7.48%
1年 パフォーマンス:
-84.88%
1日の値動き範囲:
$0.40
$0.431
1週間の範囲:
$0.38
$0.5359
52週間の値動き範囲:
$0.185
$2.99
Entero Therapeutics Inc Stock (ENTO) Company Profile
ENTO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENTO
Entero Therapeutics Inc
|
0.431 | 1.89M | 0 | 0 | 0 | 0.00 |
|
ONC
Beigene Ltd Adr
|
236.86 | 24.29B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.18 | 110.94B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2996 | 45.05M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
614.79 | 61.99B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
74.73 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
Entero Therapeutics Inc (ENTO) 最新ニュース
Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews
Entero Therapeutics names Richard Paolone interim CEO - MSN
Entero Therapeutics, Inc. SEC 10-Q Report - TradingView
Entero Therapeutics Inc Subsidiary Immunogenx Enters Settlement Agreement - marketscreener.com
Entero Therapeutics Finalizes Settlement with Mattress Liquidators - TipRanks
Entero (ENTO) Announces Public Offering of 16.67 Million Shares - GuruFocus
Pre-market Movers: CNSP, XLO, PLRZ, SGMO... - RTTNews
Layoff Tracker: Shape, Vor Cut Workforces - BioSpace
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Entero Therapeutics faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com South Africa
Entero Therapeutics faces Nasdaq delisting over equity shortfall - Investing.com
Titan Environmental Solutions Inc. Appoints Edward J. Borkowski and Edward F. Feighan to its Board of Directors - The Manila Times
Strategic Board Shake-Up: Ex-Pharma CFO and Former Congressman Join Titan Environmental's Expansion Push - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders - ACCESS Newswire
Entero Therapeutics Delays 10-K Filing - TipRanks
Celiac Disease Pipeline: Pioneering Progress with 25+ Leading - openPR.com
Entero Therapeutics Inc. (ENTO) reports earnings - Quartz
Entero Therapeutics Enters Rescission Deal to Unwind Merger With ImmunogenX - MarketScreener
Entero Therapeutics slips 7%, signs rescission agreement with ImmunogenX - MSN
Strategic Shift: Entero Therapeutics Unwinds Recent Merger and Strengthens Leadership - Stock Titan
Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC - Yahoo Finance
Micron (MU) Stock Trades Down, Here Is Why - The Globe and Mail
Johnson & Johnson plans $55 billion in US investments over the next four years - The Globe and Mail
Hogs Close with Weakness on Thursday - The Globe and Mail
With outlook uncertain, the Bank of England joins the US Fed in putting interest rates on hold - The Globe and Mail
This Under-the-Radar AI Stock Could Be 1 of the Best Buys for a Recession - The Globe and Mail
Scienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days - The Globe and Mail
European ETFs Gain Momentum as Global Markets Shift - The Globe and Mail
The Unpleasant Truth: The Stock Market Is Still Historically Pricey, Even With the Nasdaq and S&P 500 Recently Falling Into Correction Territory - The Globe and Mail
Celiac Disease Market Expected to Experience Major Growth - openPR
Significant Contract News Sends Energy Services Company Higher - The Globe and Mail
How Nvidia (NASDAQ:NVDA) Stayed One Step Ahead in the AI Race - The Globe and Mail
Super Micro's International Presence Makes It a Winning Stock - The Globe and Mail
Vicarious Surgical Names Sarah Romano as Finance Chief - MPO-mag
3 Artificial Intelligence (AI) Stocks That Can Weather President Trump's Tariff Storm - The Globe and Mail
Vicarious Surgical appoints Sarah Romano as CFO - MedTech Dive
Can Nvidia’s Stock Keep Climbing as Foxconn Bets Big on AI? - The Globe and Mail
Vicarious Surgical names Sarah Romano as new CFO By Investing.com - Investing.com Australia
Vicarious Surgical Appoints Sarah Romano as Chief Financial Officer - citybiz
Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer - Business Wire
3 Ways Tech Investors Can Navigate the Artificial Intelligence (AI) Sector Tumble - The Globe and Mail
Stocks Mixed as President Trump Ramps Up Tariffs on Canada - The Globe and Mail
Goldman Sachs: Buy These 2 ‘Rising Star’ Stocks in 2025 - The Globe and Mail
Where Will Coca-Cola Stock Be in 5 Years? - The Globe and Mail
Reflecting On Auto Parts Retailer Stocks’ Q4 Earnings: AutoZone (NYSE:AZO) - The Globe and Mail
Entero Therapeutics Inc (ENTO) 財務データ
Entero Therapeutics Inc (ENTO) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.33%
1.09%
大文字化:
|
ボリューム (24 時間):